.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing older patients with cancer requires precise tools for risk stratification. The modified G8 geriatric assessment has emerged as a promising instrument for this purpose. Recently, a retrospective study by Abe T et al. evaluated its utility in predicting treatment discontinuation. The research focused specifically on patients aged 75 and older receiving immune checkpoint inhibitor (ICI) therapy. Consequently, the results offer vital insights for clinicians managing advanced malignancies in the elderly.
The study analyzed 91 geriatric patients with a median age of 78. Researchers discovered that lower mG8 scores significantly correlate with performance status (PS) decline. Specifically, univariate logistic regression revealed a significant association with an odds ratio of 0.44. Moreover, the ROC curve analysis yielded an impressive area under the curve (AUC) of 0.848. This demonstrates that the modified G8 geriatric assessment possesses strong discriminatory power. It effectively identifies those at higher risk of early treatment intolerance before therapy even begins.
Identifying patients at risk allows for early intervention and tailored care plans. Based on the Youden index, the study suggested an exploratory cutoff of 9 points or less. However, clinicians should note that this threshold requires further validation in independent cohorts. Additionally, the mG8 provides a more streamlined alternative to the full G8 score. Therefore, pretreatment mG8 screening may optimize clinical decision-making. Furthermore, physicians should integrate these findings while referring to the latest geriatric oncology guidelines. Similarly, validating this score against the standard version remains a priority for future research.
A low score suggests a higher risk of physical decline. In this study, lower scores predicted the likelihood of stopping ICI therapy early due to deteriorating performance status.
The score helps identify frail patients who might require more intensive monitoring. Consequently, it supports personalized treatment strategies for older adults starting immunotherapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Abe T et al. Clinical utility of the modified G8 geriatric assessment in older patients with cancer treated with immune checkpoint inhibitors: A retrospective observational study. J Geriatr Oncol. 2026 May 13. doi: undefined. PMID: 42127441.
Soubeyran P, Bellera C, Goyard J, et al. Screening for frailty in older cancer patients: the G8 and the modified G8. J Clin Oncol. 2014;32(19):2020-2026. doi:10.1200/JCO.2013.51.3382.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study evaluates the modified G8 (mG8) score for predicting treatment discontinuation due to performance status decline in older cancer patients on ICIs....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
